Swethaa Manickam, MD


Psychosis in the Patient With COVID-19: An Emerging Psychopathology?

"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."

J.J. Rasimas, PhD, MD, FAACT, FACLP, FACMT, FACPsych


Perspectives on Excited Delirium and Ketamine

Parenteral ketamine is commonly used to manage agitation that is deemed severe and obstructive to necessary medical evaluation and treatment. But what does this suggest about the relationship between medicine and society?

Lynne Corner, PhD


Brain Capital: An Emerging Investment Opportunity

Brain Capital: a fresh approach to technologies and investing.

Nyapati R. Rao, MD, MS, DLFAPA


The Empty Nesters, The Pandemic, and Mia

During the pandemic, this psychiatrist is only able to connect to his beloved grandchild through FaceTime. He considers it a blessing.

Oliver Harrison


Redefining Care: Koa Health

Learn more about the company partnering with Janssen to bring high-quality, accessible, scaleable, and affordable therapeutic solutions.

Alberto Patiens, MD, PhD


COVID, the National Guard, and the US Army 

Unity with the military helped a Northeastern Hospital during the COVID-19 pandemic.

Kim Parks, MD


Normal Life Stress, They Say…

Recovery from addiction does not protect against normal life events...

Robert Roca, MD, MBA, MPH


Raising the Bar on Geriatric Mental Health Competency Training

The authors make the case for national education mandates from accreditation organizations and congressional support to require enhanced education of all clinicians who care for older adults.

Rita Cafaro, MD


Gender and Sex Issues in Bipolar Disorder

What are the differences in epidemiological and clinical characteristics of bipolar disorder between the sexes?

Marie-Eve Tremblay, PhD


Microglial Involvement With Psychiatric Diseases

This CME article briefly outlines the role that microglia play in neuropsychiatric disorders.

Karie Gibson, PsyD


Working Together to Prevent Acts of Terrorism and Violence

Don't miss this APA workshop led by experienced psychologists and psychiatrists from the FBI’s Behavioral Threat Assessment Center and the Department of Homeland Security’s National Threat Evaluation and Reporting Office!

Gabrielle Shapiro, MD


The APA Council on Children, Adolescents, and Their Families Shares Important Information on Cyberbullying

As the nation continues to grapple with the children’s mental health crisis, the American Psychiatric Association Council on Children, Adolescents, and Their Families is exploring the ways in which clinicians can best support their patients.

Darin Vercillo, MD


Celebrating Veterans

Veterans deserve our attention.

Daniel Krawczyk, PhD


Cybercriminal Exploitation of Cognitive Biases: A Brain Capital Perspective

How prioritizing brain health and brain skills could offer new solutions to this challenge.

Greg Mattingly, MD


Changing the Paradigms of How We Think About Depression

Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.

William Davies, PhD


An Update on the Presentation, Nosology, and Causes of Postpartum Psychosis

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.

Phyllis R. Peterson, MPAS, PA-C


Expanding Psychiatry’s Reach

By considering different team members, it may be possible to address the broader needs of patients with mental illness.

Charles Montano, MD


Key Takeaways for the Management of MDD

Carmen Kosicek, MSN, PMHNP-BC; Charles Montano, MD; and Gus Alva, MD, DFAPA, provide take-home messages for the management of patients with MDD and other depressive disorders.

Ayala Danzig, MD, MSW


Looking Within: The Inside Problem of Racism in Psychiatry

Racism is a problem that exists in our space. A new advocacy moment is here, and it needs to be seized.

Mona Jhaveri, PhD


Focus on Innovation

How can music help support mental health in patients with cancer and the development of cancer-fighting solutions?

Cody Zaiontz, LPC


The Healing Power of Animals

How does a love of animals affect PTSD and other mental health conditions?

Daniela Brunner, PhD


Harnessing the Power of AI Technology for Drug Discovery Treatments

What is the buzz about the power of artificial intelligence?

Lori Pittinger, MD


Neuropsychiatric Symptoms of Multiple Sclerosis

Earn CME Credit by learning more about multiple sclerosis and how it affects patients.

RJ Tesi, MD


Ushering in the Golden Era of Alzheimer Drug Development?

What effect will aducanumab have on Alzheimer disease treatment?

Matt Hoffman


FDA Approves New Medication for Migraine Prevention

The US Food and Drug Administration approves first of its kind medication for migraine prevention.

Seth D. Norrholm, PhD


Most Mass Shooters are Terrorists, Not Mentally Ill

The misperception of gunmen as “crazy” is damaging. Here’s why.

Claudia G. Heidenreich


Suicide in Older Adults: Advances and the Role of Technology in Treatment

Recent updates in suicide prevention interventions for older adults and how a novel tablet application may provide relief to individuals at high risk of suicide.

Valentim Gentil, MD, PhD


Studying Stress at a Molecular Level

If depression impairs the brain’s processes at a molecular level, would the same be true of stress more generally?

© 2023 MJH Life Sciences

All rights reserved.